Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Watching Cancer Cells Disappear During Therapy

Abstract:
Manhattan Scientifics (OTCBB: MHTX) announced today that the National Cancer Institute (NCI) has funded a grant for its Senior Scientific, LLC unit, for the use of its proprietary, highly precise magnetic cancer cell measurement in leukemia research for determining the progress of cancer treatment.

Watching Cancer Cells Disappear During Therapy

New York, NY | Posted on October 13th, 2011

Senior Scientific, LLC, founded by Edward R. Flynn, Ph.D., and currently funded by its public parent company, Manhattan Scientifics, is preparing to commercialize its nano-electromagnetic sensing technology, in collaboration with several leading cancer research hospitals in the U.S.

Senior Scientific's new monitoring therapy, which is applicable for both leukemia and solid tumors including breast cancer, can essentially watch cancer cells disappear during therapy and provide accurate guidance to physicians on how well therapy is progressing. This is important when determining the right amount of chemotherapy and avoiding overuse of chemotherapy in ways that would be harmful to patients.

Senior Scientific's nanotechnology uses a magnetic needle and targeted magnetic nanoparticles that improve determination of Minimum Residual Disease (MRD) by orders-of-magnitude. For physicians, detecting the presence of MRD provides information on how well chemotherapy is working and when it might be appropriate to stop treatment or change doses or drugs, or to restart treatment in the case of recurrence. More refined monitoring of chemotherapy is particularly important in pediatric leukemia, Flynn says, because the treatments can have significant short- and long-term adverse effects on patients.

Flynn says the technology can detect "MRD down to 0.3% of a sample. Achieving that level of sensitivity is the primary endpoint of the study, which is being conducted at the University of New Mexico's Health Sciences Center. Comparatively, current biopsy techniques typically fail to detect leukemia cells that account for less than 5% of a sample."

The grant funding by the NCI was associated with Senior Scientific's participation in the recent U.S. Department of Commerce partnership with the National Institutes of Health, the National Science Foundation and Technology Ventures Corporation (TVC) of Albuquerque.

In addition to the pre-clinical research program in measurement of MRD in leukemia, Senior Scientific has developed new approaches in early detection of breast and ovarian cancer using nanotechnology and ultra-sensitive magnetic sensors. This was funded by four Phase II SBIR grants. Results of this study have produced a technology that is orders-of-magnitude more sensitive than existing mammography without producing false positives. Other applications could include prostate cancer and immune system monitoring.

####

About Manhattan Scientifics
Manhattan Scientifics Inc. (www.mhtx.com) is located in New Mexico, New York and Montreal. It is focused on technology transfer and commercialization of disruptive technologies in the nano medicine space. The company is presently developing commercial medical prosthetics applications for its ultra fine grain metals and plans to commercialize the cancer research work and nano medical applications developed by Senior Scientific LLC, a unit of the Company.

Forward-looking statement

This press release contains forward-looking statements, which are subject to a number of risks, assumptions and uncertainties that could cause the Company's actual results to differ materially from those projected in such forward-looking statements. Management at Manhattan Scientifics believes that purchase of its shares should be considered to be at the high end of the risk spectrum. Forward-looking statements speak only as of the date made and are not guarantees of future performance. We undertake no obligation to publicly update or revise any forward-looking statements.

For more information, please click here

Contacts:
Stanton Public Relations & Marketing
880 Third Avenue
New York, NY 10022
Tel: (646) 502-3528

Corporate Offices
The Chrysler Building, 26th Floor
405 Lexington Avenue
New York, NY 10174
Tel. : (212) 541-2405
Fax. : (917) 368-8005

Copyright © Business Wire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Conductive Inks: booming to $2.8 billion by 2024 April 17th, 2014

High-temperature plasmonics eyed for solar, computer innovation April 17th, 2014

INSCX™ exchange to present Exchange trade reporting mechanism for engineered nanomaterials (NMs) to UK regulation agencies, insurers and upstream/downstream users April 17th, 2014

Transparent Conductive Films and Sensors Are Hot Segments in Printed Electronics: Start-ups in these fields show above-average momentum, while companies working on emissive displays such as OLED are fading, Lux Research says April 17th, 2014

Imaging

More effective kidney stone treatment, from the macroscopic to the nanoscale April 17th, 2014

Govt.-Legislation/Regulation/Funding/Policy

Novel stapled peptide nanoparticle combination prevents RSV infection, study finds April 17th, 2014

INSCX™ exchange to present Exchange trade reporting mechanism for engineered nanomaterials (NMs) to UK regulation agencies, insurers and upstream/downstream users April 17th, 2014

Scientists Capture Ultrafast Snapshots of Light-Driven Superconductivity: X-rays reveal how rapidly vanishing 'charge stripes' may be behind laser-induced high-temperature superconductivity April 16th, 2014

'Life Redesigned: The Emergence of Synthetic Biology' Lecture at Brookhaven Lab on Wednesday, April 30: Biomedical Engineer James Collins to Speak for BSA Distinguished Lecture Series April 16th, 2014

Nanomedicine

Novel stapled peptide nanoparticle combination prevents RSV infection, study finds April 17th, 2014

More effective kidney stone treatment, from the macroscopic to the nanoscale April 17th, 2014

High-temperature plasmonics eyed for solar, computer innovation April 17th, 2014

Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014

Announcements

More effective kidney stone treatment, from the macroscopic to the nanoscale April 17th, 2014

High-temperature plasmonics eyed for solar, computer innovation April 17th, 2014

INSCX™ exchange to present Exchange trade reporting mechanism for engineered nanomaterials (NMs) to UK regulation agencies, insurers and upstream/downstream users April 17th, 2014

Transparent Conductive Films and Sensors Are Hot Segments in Printed Electronics: Start-ups in these fields show above-average momentum, while companies working on emissive displays such as OLED are fading, Lux Research says April 17th, 2014

NanoNews-Digest
The latest news from around the world, FREE







  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE